ESC 2024 - INTERASPIRE is a global registry study among patients with recent CHD across 6 WHO regions. Kausik Ray discusses Lp(a) levels in the INTERASPIRE cohort, and implications for risk factor control and ongoing and future clinical trials.
Lp(a) in patients with recent CHD
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Kausik Ray, MD is Professor of Public Health and Consultant Cardiologist at Imperial College London, UK.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 9 September 2024
Recommended
Details
Presenters
Overview
ESC 2024 - INTERASPIRE is a global registry study among patients with recent CHD across 6 WHO regions. Kausik Ray discusses Lp(a) levels in the INTERASPIRE cohort, and implications for risk factor control and ongoing and future clinical trials.
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Kausik Ray, MD is Professor of Public Health and Consultant Cardiologist at Imperial College London, UK.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 9 September 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?